510(k) Report

510(k) · Cleared

Cleared

MyndMove, MyndMove 2.0

K233006510(k) TraditionalCleared Jun 25, 2024277-day reviewClass II21 CFR 882.5810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Myndtec, Inc. · GZI Stimulator, Neuromuscular, External Functional

Cleared on Jun 25, 2024 as substantially equivalent to K170564 (Myndtec, Inc., 2017) and 1 other predicate after a 277-day review. Its family tree reaches back 4 generations to 2011.

Decided
Jun 25, 2024
Review
277 days
Class
Class II
Product code
GZI
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K111767 (2011). No later device cites it as a predicate yet.

  1. Root · 4 generations backK111767 Ness H200 Wireless Hand Rehabilitation System User Kit and Clinican…Ness-Neuromuscular Electrical Stimulation Systems · 2011
  2. 3 generations backK123636 H200 Wireless Hand Rehabilitation System with Optional…Bioness, Inc. · 2013
  3. 2 generations backK170564 MyndMove System, MyndMove Functional Electrical StimulatorMyndtec, Inc. · 2017
  4. 1 generation backK212149 MyndMove 2.0Myndtec, Inc. · 2022
  5. This deviceK233006 MyndMove, MyndMove 2.0Myndtec, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K111767Ness H200 Wireless Hand Rehabilitation System User Kit and Clinican KitNess-Neuromuscular Electrical Stimulation Systems2011—
−3K123636H200 Wireless Hand Rehabilitation System with Optional Intelli-Connect…Bioness, Inc.2013—
−2K170564MyndMove System, MyndMove Functional Electrical StimulatorMyndtec, Inc.2017—
−1K212149MyndMove 2.0Myndtec, Inc.2022—
0 (this device)K233006MyndMove, MyndMove 2.0Myndtec, Inc.2024—
FIG. 1 — Lineage of K233006, 2011–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZI device

  1. #1 K243828 Cionic Neural Sleeve (NS-200)score 12.9 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K170564MyndMove System, MyndMove Functional Electrical Stimulator
Summary page 5
…ulator) Identification of Predicate Devices Device Applicant 510(k) No. Date Cleared MyndMove MyndTec Inc. K170564 August 30, 2017 MyndMove 2.0 MyndTec Inc. K212149 March 03, 2022 Device Description Th…
Myndtec, Inc.2017—
*K212149MyndMove 2.0
Summary page 5
…510(k) No. Date Cleared MyndMove MyndTec Inc. K170564 August 30, 2017 MyndMove 2.0 MyndTec Inc. K212149 March 03, 2022 Device Description The subject devices of K233006 include MyndMove and MyndMove 2.0. There have been no…
Myndtec, Inc.2022—

Also cleared against K170564: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 4.3 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K170564.

How does its category compare?

All GZI devices

GZI Stimulator, Neuromuscular, External Functional: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · GZI

2in 2025

2007: 42008: 12009: 12011: 62012: 22013: 22014: 32015: 12016: 12017: 62018: 22019: 22020: 22021: 12022: 42023: 12024: 22025: 2
2007high 6 (2011) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZI

110in 2022

2007: 81 days median2011: 139 days median2014: 299 days median2017: 168 days median2022: 110 days median
2007high 299 (2014) · low 81 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZI

1in 2008

2008: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZI

3in 2025

2007: 12008: 22009: 82010: 12011: 32012: 22014: 22015: 32017: 22018: 12019: 42021: 12022: 32023: 12024: 12025: 3
2007high 8 (2009) · low 0 (2013)2025

MAUDE reports naming product code GZI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200748101
20081—12
20091—08
20100—01
2011613903
20122—02
20132—00
2014329902
20151—03
20161—00
2017616802
20182—01
20192—04
20202—00
20211—01
2022411003
20231—01
20242—01
20252—03
20260—0—

What is it indicated for?

MyndMove and MyndMove 2.0 are electrical stimulation devices indicated for the following uses: Functional electrical stimulation (FES) Improvement of arm and hand function and active range of motion in patients with hemiplegia due to stroke or upper limb paralysis due to C3-T1 spinal cord injury. NeuroMuscular Electrical Stimulation (NMES) for general rehabilitation for: • maintenance and/or increase of arm and hand range of motion, • prevention and/or…

Read the full statement (119 words)

MyndMove and MyndMove 2.0 are electrical stimulation devices indicated for the following uses:

Functional electrical stimulation (FES)

Improvement of arm and hand function and active range of motion in patients with hemiplegia due to stroke or upper limb paralysis due to C3-T1 spinal cord injury.

NeuroMuscular Electrical Stimulation (NMES) for general rehabilitation for:

• maintenance and/or increase of arm and hand range of motion,

• prevention and/or retardation of disuse atrophy,

• increase in local blood circulation,

• reduction in muscle spasm, and

• re-education of muscles.

MyndMove and MyndMove 2.0 therapies can only be administered by Occupational or Physical Therapy professionals that have completed MyndMove training by MyndTec on the use of the MyndMove and MyndMove 2.0 Systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233006: MyndMove, MyndMove 2.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233006

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026